Biotech & pharma
Metastatic cancer cells implode on protein contact
By By Blaine Friedlander | 09 Jan 2014
The mouse that ROR’ed
06 Jan 2014
Stem cell scientists first to track joint cartilage development in humans
By By Shaun Mason | 06 Jan 2014
Animal cells can communicate by reaching out and touching
By By Pete Farley | 06 Jan 2014
Biologists discover solution to problem limiting development of human stem cell therapies
03 Jan 2014
New study brings scientists closer to the origin of RNA
26 Dec 2013
Chemists at the Georgia Institute of Technology have shown how molecules that may have been present on early Earth can self-assemble into structures that could represent a starting point of RNA
Biosynthesis captured in motion
26 Dec 2013
Adult stem cells found to suppress cancer while dormant
By By Shaun Mason | 24 Dec 2013
How cells remodel after UV radiation
23 Dec 2013
Speeding up gene discovery
18 Dec 2013
Researchers developing a ‘universal’ flu vaccine
18 Dec 2013
Stanford engineers are working to create a flu vaccine that could be produced more quickly and offer broader protection than what is available today
Autism-risk genes by function mapped
By By Elaine Schmidt | 13 Dec 2013
New sensor tracks zinc in cells
10 Dec 2013
Prostate cancer stem cells a moving target: research
By By Shaun Mason | 04 Dec 2013
Neanderthal viruses found in modern humans
04 Dec 2013
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
